StonvexLoading…
StonvexStonvexStonvexCore line items from DAVE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $554.18M | $347.08M | $259.09M | $204.84M |
Operating Income | $168.03M | $60.35M | $-48.40M | $-128.97M |
Net Income | $195.87M | $57.87M | $-48.52M | $-128.91M |
EPS (Diluted) | $13.53 | $4.19 | $-4.07 | $-11.12 |
Total Assets | $487.42M | $299.33M | $294.02M | $321.49M |
Total Liabilities | $134.69M | $116.23M | $206.96M | $214.93M |
Cash & Equivalents | $80.52M | $49.72M | $41.76M | $22.89M |
Free Cash Flow OCF − CapEx | $289.71M | $124.88M | $33.07M | $-45.61M |
Shares Outstanding | 14.48M | 13.82M | 11.93M | 11.59M |